EXELON sol 2 mg/ml fl 120 ml
7680550510025
CH-55051
N06DA03
01.99.0.
Reimbursement limitations:
THERAPIEBEG
En début de thérapie, application par ex. d'un test minimental.
Première évaluation intermédiaire après trois …
1 / 3
google
Details
- Product number
- 5505101
- CPT
- -
- Packaging group
- 120
- Unit
- ml
- Composition
- rivastigminum 2 mg ut rivastigmini hydrogenotartras, acidum citricum, natrii citras dihydricus, E 104, E 211 1 mg, aqua purificata, ad solutionem pro 1 ml corresp. natrium 1.82 mg.
Articles (1)
Exelon 2 mg/ml, Lösung zum Einnehmen
Lösung
120
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
1.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.82 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 91.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2000
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 55051
- Drug name
- Exelon 2 mg/ml, Lösung zum Einnehmen
- Galenic form
- LSOR
- ATC Code
- N06DA03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/06/1999
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EXELON sol 2 mg/ml fl 120 ml
- Description (DE)
- EXELON Lös 2 mg/ml Fl 120 ml
- Market launch
- 04/06/1999
- Narcotic (BTM)
- No